Shengjin Dou

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

Wu‐tong Ju, Ronghui Xia, Dongwang Zhu et al. · Nature Communications · 2022 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)

Yingying Huang, Jingjing Sun, Jun Li et al. · International Journal of Surgery · 2023 · 69 citations · Full text

Medicine, Immunology, Oncology +17

Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study

Tingting Xu, Y. Liu, Shengjin Dou et al. · Oral Oncology · 2015 · 63 citations

Medicine, Oncology, Radiation Oncology +15

<i>Fusobacterium nucleatum</i> ‐Derived Outer Membrane Vesicles Promote Immunotherapy Resistance via Changes in Tryptophan Metabolism in Tumour‐Associated Macrophages

Zhen Zhang, Ruoyi Wu, Mengying Mao et al. · Journal of Extracellular Vesicles · 2025 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Longitudinal Body Composition Changes and the Importance of Fat-Free Mass Index in Locally Advanced Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy

Huiping Ding, Shengjin Dou, Yiqun Ling et al. · Integrative Cancer Therapies · 2018 · 33 citations · Full text

Agriculture, Nutritional Sciences, Oncology +17